National COVID-19 Clinical Evidence Taskforce

The National COVID-19 Clinical Evidence Taskforce has been established to undertake continuous evidence surveillance to identify and rapidly synthesise emerging research in order to provide national, evidence-based guidelines for the clinical care of people with COVID-19. ACIPC is proud to be a member partner of the Taskforce.

The taskforce works closely with the National Infection Control Expert Group, on which ACIPC is also represented, advising the Australian Health Protection Principal Committee (AHPPC) and its other standing committees on infection prevention and control issues.